Prevention of gestational trophoblastic disease by use of actinomycin D in molar pregnancies.
D000032:Abortion, Therapeutic; D002822:Choriocarcinoma / Q000209:etiology; D006063:Chorionic Gonadotropin / Q000097:blood; D003475:Curettage; D003609:Dactinomycin / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D004106:Dilatation; D005260:Female; D005865:Gestational Age; D006801:Humans; D006828:Hydatidiform Mole / Q000188:drug therapy* / Q000473:pathology; D007044:Hysterectomy; D007263:Infusions, Parenteral; D007986:Luteinizing Hormone / Q000097:blood; D009362:Neoplasm Metastasis; D011247:Pregnancy; D014328:Trophoblastic Neoplasms / Q000150:complications / Q000473:pathology / Q000517:prevention & control*
D006063:Chorionic Gonadotropin; D003609:Dactinomycin; D007986:Luteinizing Hormone